Answers are grounded in this paper and cite their sources.
Review uncovers pathogenic roles of granzymes in neuroinflammatory conditions, highlighting their potential as therapeutic targets for neurodegenerative diseases.
Neuroinflammation is a central driver of numerous neurological disorders. While granzymes have classically been studied as cytotoxic effector molecules secreted from immune cells along with the pore-forming molecule, perforin, accumulating evidence suggests that these serine proteases also play roles in non-cytotoxic, neuroinflammatory processes. This review summarizes the current and emerging paradigms related to how granzymes contribute to the progression of neuroinflammation and neurological diseases. Taken together, current research supports a pathogenic role for granzymes as key mediators linking immune activation to neuronal damage and sustained neuroinflammation. Investigating granzyme-modulated neuroinflammatory responses in the CNS may unveil new avenues for therapeutic intervention in neuroinflammatory and neurodegenerative disorders.
No takes yet. Share an insight, caveat, or question.
Ferrari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: